Philipp Schubert

Medizinische Fakultät

De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status—results of a prospective multicenter phase II trial (DIREKHT Trial) (2024) Haderlein M, von der Grün J, Balermpas P, Rödel C, Hautmann MG, Steger F, Bohr C, et al. Journal article Treatment with (chemo)-radiation in old patients (≥76 years of age) with newly diagnosed non-metastatic squamous cell cancer of the head and neck region: real-world data from a tertiary referral center (2024) Winkler LS, Haderlein M, Semrau S, Putz F, Höfler D, Müller SK, Iro H, et al. Journal article Prostate brachytherapy boost: Long-term results of protocol-based treatment of patients with non-metastatic prostate cancer. (2024) Schweizer C, Strnad V, Merten R, Schubert P, Lotter M, Kreppner S, Fietkau R, Karius A Journal article On the implant stability in adaptive multi-catheter breast brachytherapy: Establishment of a decision-tree for treatment re-planning (2023) Karius A, Szkitsak J, Strnad V, Lotter M, Kreppner S, Schubert P, Fietkau R, Bert C Journal article Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies (2023) Weissmann T, Rückert M, Putz F, Donaubauer AJ, Hecht M, Schnellhardt S, Schubert P, et al. Journal article, Review article Unified risk analysis in radiation therapy (2022) Lohmann D, Shariff M, Schubert P, Sauer TO, Fietkau R, Bert C Journal article Die Bedeutung der Strahlentherapie im Kontext immer effektiver werdender Systemtherapien beim metastasierten NSCLC – Hinweise aus einer Rezidivanalyse nach Immuncheckpointinhibitoren (2021) Schubert P, Fietkau R, Hecht M Journal article Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors (2021) Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, et al. Journal article Reduction of elective radiotherapy treatment volume in definitive treatment of locally advanced head and neck cancer—comparison of a prospective trial with a revised simulated contouring approach (2021) Weissmann T, Speer S, Putz F, Lettmaier S, Schubert P, Shariff M, Semrau S, et al. Journal article Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors (2021) Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, et al. Conference contribution